ReferIndia News Anupam Rasayan India Gets CRISIL A+/Stable Rating Reaffirmation After Successful Acquisition Funding

ReferIndia News

✅ Secure, cloud-based clinic management.

Digital prescriptions, appointments, billing & records — all in one.

Learn More
News Image

Anupam Rasayan India Gets CRISIL A+/Stable Rating Reaffirmation After Successful Acquisition Funding

Published on: March 18, 2026, 10:57 p.m. | Source: scanx.trade

CRISIL Ratings removed Anupam Rasayan India from 'Rating Watch Negative' and reaffirmed A+/Stable ratings on Rs 1369.82 crore facilities. The positive action follows successful $150 million acquisition funding through $41 million debt and $109 million equity from Oaktree Capital. The company showed strong operational improvement with revenue rising to Rs 1,729 crore in 9M FY26 from Rs 938 crore previously, reducing inventory days from 500 to 310 days.

Checkout more news
Ad Banner

Best Surgical Oncologist in Mumbai

Advanced Robotic & Laparoscopic Cancer Surgery by Dr. Aditya Manke — expert care with faster, safer recovery. Specialist in GI, HPB, and complex cancer surgeries, delivering precision treatment with c

Know more
ReferIndia News contact